Factors associated with marburg hemorrhagic fever: Analysis of patient data from Uige, Angola

Journal of Infectious Diseases

Volumn 201, Issue 12, 2010, Pages 1909-1918

  Roddy, Paul ^a   Thomas, Sara L ^b   Jeffs, Benjamin ^a   Folo, Pascoal Nascimento ^c,d   Palma, Pedro Pablo ^a   Henrique, Bengi Moco ^c   Villa, Luis ^a   Machado, Fernando Paixao Damiao ^c   Bernal, Oscar ^a   Jones, Steven M ^e   Strong, James E ^e   Feldmann, Heinz ^e,f   Borchert, Matthias ^a,b  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Angolan Ministry of Health   (United Kingdom)

^d National Institute of Public Health   (Angola)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALGORITHM; ANGOLA; ARTHRALGIA; ARTICLE; BLEEDING; CHILD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARBURG HEMORRHAGIC FEVER; MYALGIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION; ANIMAL; COMPARATIVE STUDY; CONTACT EXAMINATION; EVALUATION; GENETICS; INFANT; ISOLATION AND PURIFICATION; MARBURG VIRUS; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

ADOLESCENT; ADULT; ANGOLA; ANIMALS; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; FEMALE; HUMANS; INFANT; MALE; MARBURG VIRUS DISEASE; MARBURGVIRUS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77952571441     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652748     Document Type: Article

References (34)

1. Siegert R, Shu HL, Slenczka W, et al. On the etiology of an unknown human infection originating from monkeys. Dtsch Med Wochenschr 1967; 92(51):2341-2343.
2. Feldmann H. Filoviridae. In: Virus taxonomy, VIIIth report of the International Committee on Taxonomy of Viruses. Fauquet CM, Mayo MA, Maniloff J, eds. London, UK: Elsevier/Academic Press, 2009:645-653.
3. Centers for Disease Control and Prevention. Outbreak of Marburg virus hemorrhagic fever - Angola, October 1, 2004-March 29, 2005. MMWR Morb Mortal Wkly Rep 2005; 54(12):308-309.
4. World Health Organization (WHO). Marburg haemorrhagic fever-fact sheet. Geneva: WHO, 2005. http://www.who.int/csr/disease/marburg/factsheet/en/index. html. Accessed 3 June 2009.
5. Towner JS, Pourrut X, Albariño CG, et al. Marburg virus infection detected in a common African bat. PLoS ONE. 2007; 2:e764. (Pubitemid 351385878)
6. Swanepoel R, Smit SB, Rollin PE, et al. Studies of reservoir hosts for Marburg virus. Emerg Infect Dis 2007; 13:1847-1851. (Pubitemid 350248485)
7. Johnson ED. Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch Virol Suppl 1996; 11:101-114.
8. Smith DH, Johnson BK, Isaacson M, et al. Marburg virus disease in Kenya. Lancet 1982; 1:816-820.
9. Gear JSS, Cassel GA, Gear AJ, et al. Outbreak of Marburg virus disease in Johannesburg. Brit Med J 1975; 4:489-493.
10. Nikiforov W, Turovskii II, Kalinin PP, et al. A case of laboratory infection with Marburg fever. Zh Mikrobiol Epidemiol Immunobiol 1994; 3:104-106.
11. World Health Organization (WHO). Marburg haemorrhagic fever imported into the Netherlands from Uganda. Geneva: WHO, 2008. http://www.who.int/csr/don/ 2008-07-10/en/index.html. Accessed 3 June 2009.
12. Centers for Disease Control and Prevention. Outbreak postings, 2009. 2008: Marburg hemorrhagic fever, imported case - United States. http://www.cdc.gov/ncidod/dvrd/spb/outbreaks/index.htm. Accessed on 2 September 2009.
13. World Health Organization (WHO). 1999-Marburg disease in Democratic Republic of Congo, update 2. Geneva: WHO, 1999. http://www.who.int/csr/don/1999- 05-06/en/. Accessed 3 June 2009.
14. Bausch DG, Borchert M, Grein T, et al. Risk factors for Marburg hemorrhagic fever, DRC. Emerg Infect Dis 2003; 9:1531-1537.
15. Bausch DG, Nichol ST, Muyembe-Tamfum JJ, et al. Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med 2006; 355 (9): 909-919. (Pubitemid 44315983)
16. World Health Organization (WHO). Marburg virus disease in Angola - update 25. 24 August 2005. Geneva: WHO, 2005. http://www.who.int/csr/don/2005-08-24/ en/index.html. Accessed 3 June 2009.
17. Colebunders R, Tshomba A, Van Kerkhove M, et al. Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment. J Infect Dis 2007; 196:S148-S153. (Pubitemid 351417254)
18. Towner JS, Sealy TK, Ksiazek TG, et al. High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis 2007; 196:S205-S212.
19. Sanchez A, Geisbert TW, Feldmann H. Marburg and Ebola viruses. In: Knipe DM and Howley PM, eds. Fields virology. 5th ed. Vol. 1. Philadelphia, PA: Wolters Kluwer/Lippincott Williams and Wilkins, 2007: 1409-1448.
20. Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription - PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004; 78:4330-4341.
21. World Health Organization (WHO). Communicable disease toolkit. Geneva: WHO, 2005. http://whqlibdoc.who.int/hq/2005/WHO-CDS-NTD-DCE-2005a-annex3.pdf. Accessed 3 June 2009.
22. World Health Organization (WHO). Marburg virus disease in Angola-update 23 March 2005. Geneva: WHO, 2005. http://www.who.int/csr/don/2005-03-23/en. Accessed 3 June 2009.
23. Jeffs B, Roddy P, Weatherill D, et al. The Médecins Sans Frontières intervention in the Marburg hemorrhagic fever epidemic, Uige, Angola, 2005. I. Lessons learned in the hospital. J Infect Dis 2007; 196(Suppl 2):S154-S161.
24. Roddy P, Weatherill D, Jeffs B, et al. The Médecins Sans Frontières intervention in the Marburg hemorrhagic fever epidemic, Uige, Angola, 2005. II. Lessons learned in the community. J Infect Dis 2007; 196(Suppl 2):S162-S167.
25. Grolla A, Lucht A, Dick D, Strong JE, Feldmann H. Laboratory diagnosis of Ebola and Marburg hemorrhagic fever. Bull Soc Pathol Exot 2005; 98(3):205-209. (Pubitemid 41500861)
26. Strong JE, Grolla, A, Jahrling PB, Feldmann H. Filoviruses and arena-viruses. In: Detrick B, Hamilotn RG, Folds JD, eds. Manual of molecular and clinical laboratory immunology. 7th ed. Washington, DC: ASM Press, 2006:774-790.
27. Quigley M, Chandramohan D, Rodrigues LC. Diagnostic accuracy of physician review, expert algorithms and data-derived algorithms in adult verbal autopsies. Int J Epidemiol 1999; 28:1081-1087. (Pubitemid 30021307)
28. Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 1999; 179 (Suppl 1):S1-S7.
29. Geisbert TW, Young HA, Jahrling PB, et al. Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis 2003; 188:1618-1629.
30. Towner JS, Khristova ML, Sealy TK, et al. Marburg virus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol 2006; 80:6497-6516.
31. Centers for Disease Control and Prevention (CDC). Update: outbreak of Ebola viral haemorrhagic fever Zaire, 1995. MMWR Morb Mortal Wkly Rep 1995; 44:468-475.
32. Borchert M., Muyembe-Tamfum JJ, Colebunders R, et al. Short communication: a cluster of Marburg virus disease involving an infant. Trop Med Int Health 2002; 7:902-906. (Pubitemid 35205377)
33. Dowell SF. Ebola haemorrhagic fever: why were children spared? Pediatr Infect Dis J 1996; 15:189-191.
34. Peters CJ. Marburg and Ebola: arming ourselves against deadly Filoviruses. N Engl J Med 2005; 352(25):2571-2573.